Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation.
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation.
复制标题
DOI:
10.1371/journal.pone.0256813
复制
发表时间:
2021
期刊:
影响因子:
3.7
通讯作者:
Martinez-Nunez RT
中科院分区:
文献类型:
--
作者:
Lista MJ;Matos PM;Maguire TJA;Poulton K;Ortiz-Zapater E;Page R;Sertkaya H;Ortega-Prieto AM;Scourfield E;O'Byrne AM;Bouton C;Dickenson RE;Ficarelli M;Jimenez-Guardeño JM;Howard M;Betancor G;Galao RP;Pickering S;Signell AW;Wilson H;Cliff P;Kia Ik MT;Patel A;MacMahon E;Cunningham E;Doores K;Agromayor M;Martin-Serrano J;Perucha E;Mischo HE;Shankar-Hari M;Batra R;Edgeworth J;Zuckerman M;Malim MH;Neil S;Martinez-Nunez RT
There is a worldwide need for reagents to perform SARS-CoV-2 detection. Some laboratories have implemented kit-free protocols, but many others do not have the capacity to develop these and/or perform manual processing. We provide multiple workflows for SARS-CoV-2 nucleic acid detection in clinical samples by comparing several commercially available RNA extraction methods: QIAamp Viral RNA Mini Kit (QIAgen), RNAdvance Blood/Viral (Beckman) and Mag-Bind Viral DNA/RNA 96 Kit (Omega Bio-tek). We also compared One-step RT-qPCR reagents: TaqMan Fast Virus 1-Step Master Mix (FastVirus, ThermoFisher Scientific), qPCRBIO Probe 1-Step Go Lo-ROX (PCR Biosystems) and Luna® Universal Probe One-Step RT-qPCR Kit (Luna, NEB). We used primer-probes that detect viral N (EUA CDC) and RdRP. RNA extraction methods provided similar results, with Beckman performing better with our primer-probe combinations. Luna proved most sensitive although overall the three reagents did not show significant differences. N detection was more reliable than that of RdRP, particularly in samples with low viral titres. Importantly, we demonstrated that heat treatment of nasopharyngeal swabs at 70°C for 10 or 30 min, or 90°C for 10 or 30 min (both original variant and B 1.1.7) inactivated SARS-CoV-2 employing plaque assays, and had minimal impact on the sensitivity of the qPCR in clinical samples. These findings make SARS-CoV-2 testing portable in settings that do not have CL-3 facilities. In summary, we provide several testing pipelines that can be easily implemented in other laboratories and have made all our protocols and SOPs freely available at https://osf.io/uebvj/.
登录
查看更多内容
DOI:
10.1126/science.abg3055
发表时间:
2021-04-09
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Davies NG;Abbott S;Barnard RC;Jarvis CI;Kucharski AJ;Munday JD;Pearson CAB;Russell TW;Tully DC;Washburne AD;Wenseleers T;Gimma A;Waites W;Wong KLM;van Zandvoort K;Silverman JD;CMMID COVID-19 Working Group;COVID-19 Genomics UK (COG-UK) Consortium;Diaz-Ordaz K;Keogh R;Eggo RM;Funk S;Jit M;Atkins KE;Edmunds WJ
通讯作者:
Edmunds WJ
影响因子:
9.8
作者:
Reijns MAM;Thompson L;Acosta JC;Black HA;Sanchez-Luque FJ;Diamond A;Parry DA;Daniels A;O'Shea M;Uggenti C;Sanchez MC;O'Callaghan A;McNab MLL;Adamowicz M;Friman ET;Hurd T;Jarman EJ;Chee FLM;Rainger JK;Walker M;Drake C;Longman D;Mordstein C;Warlow SJ;McKay S;Slater L;Ansari M;Tomlinson IPM;Moore D;Wilkinson N;Shepherd J;Templeton K;Johannessen I;Tait-Burkard C;Haas JG;Gilbert N;Adams IR;Jackson AP
通讯作者:
Jackson AP
影响因子:
9.3
作者:
Pan, Yang;Long, Luyao;Ren, Simei
通讯作者:
Ren, Simei
DOI:
10.1099/jgv.0.001539
发表时间:
2021-03
期刊:
The Journal of general virology
影响因子:
--
作者:
Auerswald H;Yann S;Dul S;In S;Dussart P;Martin NJ;Karlsson EA;Garcia-Rivera JA
通讯作者:
Garcia-Rivera JA
DOI:
10.1016/j.jcv.2020.104423
发表时间:
2020-07-01
期刊:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
影响因子:
--
作者:
Merindol, Natacha;Pepin, Genevieve;Danylo, Alexis
通讯作者:
Danylo, Alexis